Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
<p>Abstract</p> <p>Background</p> <p>HMG-CoA reductase inhibitors (statins) are commonly used in medicine to control blood lipid disorder. Large clinical trials have demonstrated that statins greatly reduces cardiovascular-related morbidity and mortality in patients wit...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2004-05-01
|
| Series: | Lipids in Health and Disease |
| Online Access: | http://www.lipidworld.com/content/3/1/7 |
| Summary: | <p>Abstract</p> <p>Background</p> <p>HMG-CoA reductase inhibitors (statins) are commonly used in medicine to control blood lipid disorder. Large clinical trials have demonstrated that statins greatly reduces cardiovascular-related morbidity and mortality in patients with and without coronary artery disease. Also, the use of HMG-CoA reductase inhibitors has been reported to have immunosuppressive effects.</p> <p>Case presentation</p> <p>We describe an unusual case of regression of vitiligo in a patient treated with high dose simvastatin. The relation between simvastatin and regression of vitiligo in this case report may be related to the autoimmune pathophysiology of the disease.</p> <p>Conclusion</p> <p>This unexpected beneficial impact provides another scientific credence to the hypothesis that immune mechanisms play a role in the development of vitiligo and that the use of statins as immuno-modulator could be of use not only for treatment relative to organ transplant but in other pathologies such as vitiligo.</p> |
|---|---|
| ISSN: | 1476-511X |